Public Officials Liability (POL) insurance remains a core component of risk management for governmental entities across the United States. This specialized coverage, often structured as a public-sector adaptation of Directors and Officers (D&O) insurance, addresses the distinct personal and entity-level exposures faced by elected officials, appointed leaders, and public employees.
Decisions to switch from an insurer or insurance broker are often driven by the potential for cost savings, improved terms, or better service. For risk managers, corporate executives, and consultants these transitions promise optimization but carry substantial hidden dangers.
The current U.S. Directors and Officers (D&O) liability insurance market is defined by a striking paradox: declining frequency of traditional securities class actions (SCAs) alongside sharply rising claim severity and a surge in insolvency-related and derivative litigation.
The Delaware Superior Court ruled in favor of AMC after looking at the policy's definition of "loss".
The U.S. Directors and Officers (D&O) liability insurance market in 2026 is stabilizing after a period of softening. Increased capacity has kept competition strong, resulting in flat or modestly decreased premiums for many insureds. This article examines the competitive equilibrium as underlying risks evolve rapidly.
From late 2025 to early 2026, D&O liability and coverage law saw major changes, with Delaware continuing to play a leading role. These developments highlight Delaware's tendency to interpret D&O policy exclusions in a manner beneficial to insureds, setting important precedents for future litigation.
Artificial intelligence and autonomous technologies are rapidly changing liability risks, with traditional insurance policies struggling to cover these new exposures. Insurers are responding with new exclusions and specialized products, and policyholders must review their coverage, consult insurers about dedicated AI solutions, and negotiate endorsements for emerging risks.
Per- and polyfluoroalkyl substances—known as "forever chemicals" due to their extreme persistence in the environment and human body—continue to fuel one of the largest and most complex mass tort waves in U.S. history. While water contamination settlements have advanced, personal injury outcomes remain uncertain, placing significant pressure on umbrella and excess liability programs.
Directors and Officers (D&O) liability exposures continue to evolve at an accelerated pace. Traditional securities class actions (SCAs) now intersect with new technological, regulatory, and global pressures, placing heightened personal accountability on boards and executives. The core driver is still the obligation to implement reasonable oversight systems for material risks—with courts increasingly willing to scrutinize whether directors adequately monitored emerging threats like artificial intelligence (AI), cyber incidents, and geopolitical disruptions.
In the world of Directors and Officers (D&O) insurance, three sneaky endorsements—known here as the Terrible Three—can quietly gut your policy's protection, leaving executives exposed to devastating personal liability. Don't let these hidden traps catch you off guard. Here’s what you need to know.